Skip to content

Comparison of three techniques for injection of steroid in back in patients suffering from low back pain

Transforaminal versus lateral parasagittal Versus Midline Interlaminar Lumbar Epidural Steroid Injection for Management of Low Back Pain with Lumbosacral Unilateral Radicular Pain: A Double-Blind, Randomized Study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/01/006514
Enrollment
60
Registered
2016-01-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Low back pain with unilateral radicular component

Interventions

Intervention1: Interlaminar group: Midline orientation of the needle will be maintained throughout the procedure.Epidural space will be identified using the loss-of-resistance to saline technique. Aft

Sponsors

Post Graduate Institute Of Medical Education Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Low back pain with unilateral lumbosacral radicular pain (sharp, shooting or lacanting pain perceived in skin and deep) for at least 3 month duration not responding to medication and physical therapies • BMD T score of more than â?? 1.0 SD of the total hip and spine. • Evidence of magnetic resonance imaging (MRI) of disc herniation at 1-2 levels.

Exclusion criteria

Exclusion criteria: Patient with history of surgery on lumbar Spine, Spinal canal stenosis, spondylolisthesis Allergic to contrast or steroid . Bleeding diathesis, Patient who received lumbar epidural steroid injection in past six months or using systemic steroid for pain relief Pregnant patients History of disease known to affect bone turnover, Documentation of abnormal serum thyrotropin levels, high parathyroid hormone levels, or using drugs known to affect bone metabolism, History of intake of oral, parenteral, or inhaled glucocorticoids for more than 4 weeks or an intra-articular injection in the preceding year.

Design outcomes

Primary

MeasureTime frame
Primary aim of our study will be the incidence of patients achieving effective pain relief(defined as decrease in VAS score by 50%)Timepoint: Primary aim of our study will be the incidence of patients achieving effective pain relief(defined as decrease in VAS score by 50%)

Secondary

MeasureTime frame
Contrast spread pattern Overall VAS scores Number of injections required Bone marrow density- Baseline and 3months Serum calcium levels, vit D3 levels S Osteocalcin levels Timepoint: Baseline and 3 months

Countries

India

Contacts

Public ContactJeetinder kaur

PGIMER

nscjk2006@gmail.com7087009510

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026